Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1018 results for "usfda"

Aurobindo gets USFDA approval for anti-infection drug
Business Standard

Aurobindo Pharma gains after USFDA nod for Amoxicillin generic

Aurobindo Pharma rose 2.45% to Rs 875.25 at 9:20 IST on BSE after the company said it received approval from the US health regulator to market generic version of Amoxicillin in the US market. The announcement was made after market hours on Tuesday, 16 ... Business Standard, 11 hours ago

44 images for usfda

Money Today, 1 day ago
MSN India, 5 days ago
Business Standard, 5 hours ago
Financial Express, 2 weeks ago
IndiaVision, 5 days ago
Medical Design Technology, 1 week ago, 2 weeks ago
Business Standard, 1 week ago, 3 weeks ago
Business Standard, 2 weeks ago

Aurobindo shares move up on USFDA nod for Amoxicillin

, one of the leading drug makers, witnessed a rise in share prices on Wednesday after the company has received new product approval from the US Food & Drug Administration (USFDA). The product approval will allow the company to manufacture and market ...
 Myiris9 hours ago
Business Standard

Sun, Ranbaxy fall on surprise inspection by USFDA

MUMBAI: Shares of Sun Pharma and Ranbaxy dipped 2% each on Friday on the BSE, extending their previous day's fall on reports of drug regulator, US Food and Drug Administration (FDA) conducting a surprise inspection of Sun Pharma's manufacturing ...
 Times of India4 days ago USFDA may extend audit at Sun Pharma's Halol facility  Money Control5 days ago Sun Pharma falls 6% as USFDA inspects Halol unit; facility contributes 40% of US sales  Economic Times6 days ago Sun Pharma declines 6% after FDA inspected plant report  Business Standard6 days ago
Money Today

Connecticut AG George Jepsen to USFDA: Pull up Ranbaxy for failing to launch drug Nexium

NEW DELHI: Ranbaxy Laboratories is facing increasing pressure from different states in the US, rival generic drugmakers, consumer groups, drug retailers and wholesalers to either immediately bring to market the first generic version of ...
 Economic Times4 days ago Ranbaxy shares jump on drug approval by USFDA  The Hindu2 months ago Ranbaxy stock up on USFDA nod for generic drug  Money Today2 months ago Ranbaxy Laboratories rallies over 8% on USFDA nod for Diovan's generic version  Economic Times2 months ago

Sun Pharma unit under USFDA scrutiny, stocks dip

STATESMAN NEWS SERVICE Mumbai, 11 September The stock of Sun Pharmaceuticals Industries lost more than 6 per cent today following reports that two inspection teams from the United States Food and Drug Administration have begun scrutiny of ...
 The Statesman5 days ago

Sun Pharma shares fall over 2% on USFDA concerns

The stock has fallen on reports that Halol plant in Gujarat has been subjected to surprise inspection by the American drug regulator USFDA. NEW DELHI: After falling 4 per cent in the previous session, shares of Sun Pharmaceuticals plunged as much as 2.3 per ...
 Economic Times5 days ago Sun Pharma shares fall over 2%; slips for second day in a row on US FDA concerns  Economic Times5 days ago

USFDA publishes its Purple Book

 Bio Spectrum Asia6 days ago
Business Standard

Wockhardt's 2 drugs receive USFDA's QIDP status

QIDP status allows for fast track review of the drug application by USFDA paving way for an early launch fast-tracks approval for Wockhardt drugs BS B2B Bureau | Mumbai September 3, 2014 Last Updated at 12:15 IST The US Food and Drug Administration (USFDA) ...
 Business Standard2 weeks ago Will take 2-2.5 yrs for phase-3 clinical trails: Wockhardt  Money Control2 weeks ago Wockhardt gains after USFDA agrees to fast track approval for two novel drugs  Hindu Business Line2 weeks ago Wockhardt drug discovery fast track nod by USFDA  Press Trust of India2 weeks ago
International Business Times India

USFDA Issues Warning to Indian Drug Maker Marck Biosciences

FDA investigators identified significant violations of cGMP regulations for finished pharmaceuticals during inspections from 29 October to 1 November 2013 at the Kheda, India manufacturing facility of Marck Biosciences, according to an FDA warning ...
 PharmaAsia2 weeks ago USFDA issues warns Marck Biosciences for GMP violation  Business Standard3 weeks ago USFDA issues warning to Marck Biosciences  Economic Times3 weeks ago USFDA to add Personnel in India to Boost Inspection  International Business Times India1 month ago

Natco Pharma gains 5%; hits 52-week high

company announced that its marketing partner in the USA, Mylan Inc has filed ANDA and has been accepted by USFDA SI Reporter | Mumbai September 1, 2014 Last Updated at 13:25 IST Natco Pharma has gained 5% to Rs 1267 also its 52-week high on the BSE after the ...
 Business Standard2 weeks ago Expect double-digit growth in FY15: Nectar Life  Moneycontrol.com3 weeks ago Indoco Remedies spurts 14% after USFDA approves Goa plants  Myiris1 month ago Indoco Remedies rallies 20%, hits 52-week high after USFDA approves plants  Economic Times1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - usfda
Get updated on latest news & your favorite topics right in your inbox!
More     Less